Jeddah, Saudi Arabia headquartered Abdul Latif Jameel Health, and Wellesta Holdings, a Singapore headquartered company announced a new agreement for the marketing and distribution of the Butterfly iQ+ point-of-care ultrasound device in India.
The companies will register Butterfly iQ+ in India and start promoting and selling the product in the country in the fourth quarter of 2022, bringing this technology to a potential 1.2 million registered physicians in the country. Butterfly iQ+ is a hand-held 4-in-1 single probe whole-body innovative point-of-care ultrasound device powered by the world’s first Ultrasound-on-Chip technology, according to the company.
Hailed as potentially the ‘stethoscope of the future’, the Butterfly iQ+ transforms what can sometimes be complex processes, into one connected and integrated point-of-care ultrasound (POCUS) system to help collect advanced imaging, perform rapid assessments, and guide critical procedures. It allows the sharing of results seamlessly with doctors across the globe to help read and interpret scans.
Last updated: December 26th, 2025
